Literature DB >> 9201649

Neuroendocrine correlates of chronic fatigue syndrome: a brief review.

M A Demitrack1.   

Abstract

Chronic fatigue syndrome remains one of the more perplexing syndromes in contemporary clinical medicine. One approach to understanding this condition has been to acknowledge its similarities to other disorders of clearer pathophysiology. In this review, a rationale for the study of neuroendocrine correlates of chronic fatigue syndrome is presented, based in part on the clinical observation that asthenic or fatigue states share many of the somatic symptom characteristics seen in recognized endocrine disorders. Of additional interest is the observation that psychological symptoms, particularly disturbances in mood and anxiety, are equally prominent in this condition. At this time, several reports have provided replicated evidence of disruptions in the integrity of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. It is notable that the pattern of the alteration in the stress response apparatus is not reminiscent of the well-understood hypercortisolism of melancholic depression but, rather, suggests a sustained inactivation od central nervous system components of this system. Recent work also implicates alterations in central serotonergic tone in the overall pathophysiology of this finding. The implications of these observations are far from clear, but they highlight the fact that, though chronic fatigue syndrome overlaps with the well-described illness category of major depression, these are not identical clinical conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201649     DOI: 10.1016/s0022-3956(96)00059-3

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  7 in total

1.  Physiological differences between burnout patients and healthy controls: blood pressure, heart rate, and cortisol responses.

Authors:  W De Vente; M Olff; J G C Van Amsterdam; J H Kamphuis; P M G Emmelkamp
Journal:  Occup Environ Med       Date:  2003-06       Impact factor: 4.402

2.  A pilot study of cognitive behavioral stress management effects on stress, quality of life, and symptoms in persons with chronic fatigue syndrome.

Authors:  Corina Lopez; Michael Antoni; Frank Penedo; Donna Weiss; Stacy Cruess; Mary-Catherine Segotas; Lynn Helder; Scott Siegel; Nancy Klimas; Mary Ann Fletcher
Journal:  J Psychosom Res       Date:  2011-01-15       Impact factor: 3.006

Review 3.  Chronic fatigue syndrome: an update.

Authors:  R J Shephard
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

4.  Ghrelin plasmatic levels in patients with fibromyalgia.

Authors:  Miguel Otero; Ruben Nogueiras; Francisca Lago; Juan Meijide; Juan Amarelo; Antonio Mera; Juan Gomez-Reino; Oreste Gualillo
Journal:  Rheumatol Int       Date:  2003-09-05       Impact factor: 2.631

Review 5.  Importance of fatigue and its measurement in chronic liver disease.

Authors:  Lynn H Gerber; Ali A Weinstein; Rohini Mehta; Zobair M Younossi
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

6.  Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns.

Authors:  Malav S Trivedi; Elisa Oltra; Leonor Sarria; Natasha Rose; Vladimir Beljanski; Mary Ann Fletcher; Nancy G Klimas; Lubov Nathanson
Journal:  PLoS One       Date:  2018-07-23       Impact factor: 3.240

Review 7.  Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease.

Authors:  Anca D Petrescu; Jessica Kain; Victoria Liere; Trace Heavener; Sharon DeMorrow
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-12       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.